1-3 of 3
Jennifer Picarsic
Close
Sort by
Journal Articles

Lineage switching of the cellular distribution of BRAF V600E in multisystem Langerhans cell histiocytosis

Clinical Trials & Observations
Paul Milne, Simon Bomken, Olga Slater, Ashish Kumar, Adam Nelson, Somak Roy, Jessica Velazquez, Kshitij Mankad, James Nicholson, Dan Yeomanson, Richard Grundy, Ahmed Kamal, Anthony Penn, Jane Pears, Gerard Millen, Bruce Morland, James Hayden, Jason Lam, Maymoon Madkhali, Jamie MacDonald, Preeti Singh, Sarah Pagan, Carlos Rodriguez-Galindo, Milen Minkov, Jean Donadieu, Jennifer Picarsic, Carl Allen, Venetia Bigley, Matthew Collin
Journal: Blood Advances
Blood Adv (2023) 7 (10): 2171–2176.
https://doi.org/10.1182/bloodadvances.2021006732
Published: 2023
Includes: Supplemental data
Journal Articles

Dasatinib induces a dramatic response in a child with refractory juvenile xanthogranuloma with a novel MRC1-PDGFRB fusion

Clinical Trials & Observations
Shaimaa S. Eissa, Michael R. Clay, Teresa Santiago, Gang Wu, Lu Wang, Barry L. Shulkin, Jennifer Picarsic, Kim E. Nichols, Patrick K. Campbell
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2991–2995.
https://doi.org/10.1182/bloodadvances.2020001890
Published: 2020
Journal Articles

BRAF -V600E–mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor

Clinical Trials & Observations
Rosemarie Mastropolo, Allison Close, Steven W. Allen, Kenneth L. McClain, Scott Maurer, Jennifer Picarsic
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1848–1853.
https://doi.org/10.1182/bloodadvances.2019000093
Published: 2019
Includes: Supplemental data